Login to Your Account



Other News To Note


Monday, September 17, 2012
• Io Therapeutics Inc., of Santa Ana, Calf., presented preclinical data for its compound IRX4204 in animal models of Alzheimer's disease at the 6th Neurodegenerative Conditions Research and Development conference in San Francisco. The results showed attenuation of cognitive deterioration.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription